| |
| |
|
| Insider
Information: |
Mahoney Michael F |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,696,927 |
|
|
Indirect Shares
|
196,852 |
|
|
| Direct
Value |
$130,294,622 |
|
|
|
Indirect Value
|
$14,438,075 |
|
|
| Total
Shares |
1,893,779 |
|
|
| Total
Value |
$144,732,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 10.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
Chairman, President & ... |
2024-02-18 |
1,673,878 |
2024-02-18 |
176,245 |
Premium* |
|
|
Baxter International Inc |
BAX |
Director |
2023-05-02 |
9,692 |
2023-05-02 |
20,397 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
Director |
2024-05-16 |
13,357 |
2024-05-16 |
210 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
190 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
95,919 |
1,594,841 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-03-01 |
4 |
AS |
$16.96 |
$1,695,600 |
D/D |
(100,000) |
1,832,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-04-01 |
4 |
AS |
$18.90 |
$1,890,270 |
D/D |
(100,000) |
1,732,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-05-02 |
4 |
AS |
$22.12 |
$2,212,270 |
D/D |
(100,000) |
1,632,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-06-01 |
4 |
AS |
$22.69 |
$2,268,650 |
D/D |
(100,000) |
1,532,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-07-01 |
4 |
AS |
$23.43 |
$2,342,570 |
D/D |
(100,000) |
1,432,577 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2019-02-20 |
4 |
D |
$40.11 |
$4,131,811 |
D/D |
(103,012) |
1,974,530 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-02-12 |
4 |
D |
$26.18 |
$2,764,791 |
D/D |
(105,607) |
2,059,193 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2012-11-01 |
4 |
D |
$5.24 |
$567,544 |
D/D |
(108,310) |
255,359 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
108,797 |
2,069,218 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-09-12 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-09-12 |
4 |
AS |
$53.91 |
$6,110,447 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-10-09 |
4 |
OE |
$13.08 |
$1,662,514 |
D/D |
113,355 |
1,612,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-10-09 |
4 |
AS |
$52.09 |
$5,904,481 |
D/D |
(113,355) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-11-06 |
4 |
AS |
$52.51 |
$5,951,983 |
D/D |
(113,356) |
1,498,922 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2023-11-06 |
4 |
OE |
$13.08 |
$1,662,527 |
D/D |
113,356 |
1,612,278 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
President & CEO |
• • – |
2016-01-01 |
4 |
D |
$18.44 |
$2,094,028 |
D/D |
(113,559) |
1,579,039 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-09-10 |
4 |
AS |
$35.88 |
$4,186,104 |
D/D |
(116,666) |
2,023,104 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-10-01 |
4 |
AS |
$38.80 |
$4,526,466 |
D/D |
(116,666) |
1,906,438 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2018-11-01 |
4 |
AS |
$36.35 |
$4,240,739 |
D/D |
(116,666) |
1,789,772 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-10-03 |
4 |
AS |
$39.34 |
$4,949,556 |
D/D |
(125,827) |
1,767,665 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-10-03 |
4 |
OE |
$7.39 |
$1,176,011 |
D/D |
125,827 |
1,893,492 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-11-07 |
4 |
AS |
$41.97 |
$5,280,997 |
D/D |
(125,827) |
1,767,665 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-11-07 |
4 |
OE |
$7.39 |
$1,176,011 |
D/D |
125,827 |
1,893,492 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Chairman, President & CEO |
• • – |
2022-08-08 |
4 |
AS |
$40.97 |
$5,154,682 |
D/D |
(125,828) |
2,133,122 |
0 |
% |
|
190 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
